ATE181240T1 - Verwendung von somatostatinanalogen zur behandlung von melanomen - Google Patents

Verwendung von somatostatinanalogen zur behandlung von melanomen

Info

Publication number
ATE181240T1
ATE181240T1 AT92906420T AT92906420T ATE181240T1 AT E181240 T1 ATE181240 T1 AT E181240T1 AT 92906420 T AT92906420 T AT 92906420T AT 92906420 T AT92906420 T AT 92906420T AT E181240 T1 ATE181240 T1 AT E181240T1
Authority
AT
Austria
Prior art keywords
melanoma
treatment
somatostatin analogue
skin
malignant
Prior art date
Application number
AT92906420T
Other languages
English (en)
Inventor
Arthur E Bogden
Jacques-Pierre Moreau
Original Assignee
Biomeasure Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomeasure Inc filed Critical Biomeasure Inc
Application granted granted Critical
Publication of ATE181240T1 publication Critical patent/ATE181240T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT92906420T 1991-02-08 1992-02-07 Verwendung von somatostatinanalogen zur behandlung von melanomen ATE181240T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65286391A 1991-02-08 1991-02-08

Publications (1)

Publication Number Publication Date
ATE181240T1 true ATE181240T1 (de) 1999-07-15

Family

ID=24618499

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92906420T ATE181240T1 (de) 1991-02-08 1992-02-07 Verwendung von somatostatinanalogen zur behandlung von melanomen

Country Status (12)

Country Link
US (1) US6087337A (de)
EP (1) EP0542934B1 (de)
JP (1) JPH05506254A (de)
AT (1) ATE181240T1 (de)
CA (1) CA2079896A1 (de)
DE (1) DE69229436T2 (de)
DK (1) DK0542934T3 (de)
ES (1) ES2134798T3 (de)
GR (1) GR3030856T3 (de)
IE (1) IE920416A1 (de)
PT (1) PT100111B (de)
WO (1) WO1992013554A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783170A (en) * 1991-11-27 1998-07-21 Diatide, Inc. Peptide-metal chelate conjugates
US6017512A (en) * 1992-06-23 2000-01-25 Diatide, Inc. Radiolabeled peptides
US5716596A (en) * 1992-06-23 1998-02-10 Diatide, Inc. Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
US5620675A (en) 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
US5871711A (en) * 1992-06-23 1999-02-16 Diatide, Inc. Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses
US5932189A (en) * 1994-07-29 1999-08-03 Diatech, Inc. Cyclic peptide somatostatin analogs
US6051206A (en) * 1994-06-03 2000-04-18 Diatide, Inc Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
DK3007704T3 (da) * 2013-06-13 2021-03-29 Antisense Therapeutics Ltd Kombinationsterapi til akromegali

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904594A (en) * 1973-07-02 1975-09-09 Salk Inst For Biological Studi Somatostatin and acylated des-(ala' 1', gly' 2') derivatives thereof
US4235886A (en) * 1979-10-31 1980-11-25 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
US4310518A (en) * 1979-10-31 1982-01-12 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
DE3062075D1 (en) * 1979-11-27 1983-03-24 Sandoz Ag Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use
US4360516A (en) * 1981-04-13 1982-11-23 Merck & Co., Inc. Modified D-retro cyclic hexapeptide somatostatin analogs
US4485101A (en) * 1983-10-11 1984-11-27 Administrators Of The Tulane Educational Fund Peptides
GB8423431D0 (en) * 1984-09-17 1984-10-24 Sandoz Ltd Organic compounds
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides
US4585755A (en) * 1985-04-29 1986-04-29 Merck & Co., Inc. Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents
US4904642A (en) * 1985-09-12 1990-02-27 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
US4853371A (en) * 1986-06-17 1989-08-01 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
US4871717A (en) * 1987-01-07 1989-10-03 Administrators Of The Tulane Educational Fund Peptides
DK375789A (da) * 1988-08-18 1990-02-19 Syntex Inc Peptidderivater
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
WO1990012811A1 (en) * 1989-04-26 1990-11-01 The Administrators Of The Tulane Educational Fund Linear somatostatin analogs
DE69027767T2 (de) * 1989-12-08 1997-01-02 Univ Tulane Oktapeptidanaloge von somatostatin mit threonin in position 6
GB9004017D0 (en) * 1990-02-22 1990-04-18 Krenning Eric P Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
DE69229436D1 (de) 1999-07-22
EP0542934A1 (de) 1993-05-26
US6087337A (en) 2000-07-11
ES2134798T3 (es) 1999-10-16
EP0542934A4 (en) 1993-07-07
JPH05506254A (ja) 1993-09-16
CA2079896A1 (en) 1992-08-09
DK0542934T3 (da) 1999-11-22
PT100111B (pt) 1999-06-30
EP0542934B1 (de) 1999-06-16
WO1992013554A1 (en) 1992-08-20
IE920416A1 (en) 1992-08-12
PT100111A (pt) 1993-06-30
DE69229436T2 (de) 1999-11-25
GR3030856T3 (en) 1999-11-30

Similar Documents

Publication Publication Date Title
DE69733834D1 (de) Thyroxin-analoge mit keiner signifikanten hormonellen aktivität zur behandlung von bösartigen tumoren
ATE105482T1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
ATE222489T1 (de) Thyroxin-analoga ohne bedeutende hormonale wirkung zur behandlung von bösartigen tumoren
ATE390932T1 (de) Verwendung von glp-1 oder analogen zur behandlung von myokardischem infarkt
ATE284959T1 (de) Unterbrechung der bindung der proteine mdm2 und p53 und entsprechende therapeutische anwendung
EA200000723A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
DK0380230T3 (da) Immunogene sammensætninger mod gastrin-peptider
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
DE69921156D1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
ATE93138T1 (de) Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie.
DK130387A (da) Transglutaminase inhibitorer
DE69535264D1 (de) Verfahren zur behandlung von diabetes mittels kgf
ATE311853T1 (de) Verwendung von krillenzymen zur behandlung von zahnbelag
ATE218350T1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
ATE181240T1 (de) Verwendung von somatostatinanalogen zur behandlung von melanomen
DE3854121D1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
ATE217191T1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
ATE251631T1 (de) Dipohosphonsäuresalze für die behandlung von osteoporose
ATE281841T1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
ATE222491T1 (de) Melatonin-derivate zur verwendung in der behandlung von schlafstörungen
ATE114468T1 (de) Ethyl-(+)-apovincaminat zur behandlung der demyelinisierung klinischer erscheinungen autoimmunen ursprungs.
DE69218200D1 (de) Behandlung von leberkrebs
ATE227991T1 (de) Verwendung von topotecan in der behandlung von nichtkleinzelligen lungenkarzinomen
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
DE69635282D1 (de) Behandlung der exzessiven aggressivität mit olanzapine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee